SDB-005: Difference between revisions
CSV import |
CSV import |
||
| Line 24: | Line 24: | ||
{{Chem-stub}} | {{Chem-stub}} | ||
{{Pharma-stub}} | {{Pharma-stub}} | ||
== SDB-005 == | |||
<gallery> | |||
File:SDB-005 structure.png|SDB-005 structure | |||
File:originalSDB005 structure.png|Original SDB-005 structure | |||
</gallery> | |||
Latest revision as of 01:30, 20 February 2025
SDB-005 is a research chemical that belongs to the indazole class of cannabinoids. It is an analogue of JWH-018, which is a synthetic cannabinoid found in several versions of the herbal mixture Spice. SDB-005 is known for its potent psychoactive effects and is often used in scientific research.
Chemistry[edit]
SDB-005 is a member of the indazole class of cannabinoids, more specifically, it is an indazole-3-carboxamide type. It is closely related to the better studied compound JWH-018. The molecular formula of SDB-005 is C23H22N2O2.
Pharmacology[edit]
The pharmacology of SDB-005 is primarily based on its action as an agonist at the cannabinoid receptors CB1 and CB2. It is known to produce effects similar to tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. However, the exact mechanism of action and the full spectrum of effects are still under investigation.
Legality[edit]
The legality of SDB-005 varies by country. In some countries, it is classified as a controlled substance due to its structural similarity to other banned synthetic cannabinoids. In others, it remains legal for research purposes but is not approved for human consumption.
Risks and Safety[edit]
As with all research chemicals, the use of SDB-005 carries potential risks. These may include physical health risks, such as heart problems and seizures, as well as mental health risks, such as psychosis and addiction. Due to the lack of comprehensive studies on its effects in humans, all potential risks may not be known.
See Also[edit]
SDB-005[edit]
-
SDB-005 structure
-
Original SDB-005 structure

